Posts Tagged LSVT Global

Announcing the 2018 LSVT Global Student Grant Awardees for Speech-Language Pathology

We congratulate the 2018 speech-language pathology student grant recipients! The awardees are conducting exciting speech treatment research in the areas of aphasia and amyotrophic lateral sclerosis (ALS). Read on to learn about the 2018 winners and our 2019 grant competition!

Continue Reading

Congratulations to Dr. Cynthia Fox on being appointed as Chief Executive Officer of LSVT Global, Inc.

The Board of Directors of LSVT Global, Inc. is very pleased to announce the appointment of Dr. Cynthia Fox as Chief Executive Officer.  This new appointment grants Dr. Fox greatly expanded governance roles and responsibilities.  She will also continue to oversee the day-to-day operations of the company. As one of the Founders of LSVT Global, Dr. Fox has the experience and vision to lead the company as it broadens the reach of its current range of therapies and products and invests in new initiatives to grow the company.  LSVT Global develops innovative treatments that improve the speech and movement of people with Parkinson’s disease (PD) and other neurological conditions. We train speech, physical and occupational therapists around the world in these treatments so that they can positively impact the lives of their patients.  Continue Reading